High versus low mean arterial pressure target in liver transplant patients. An open, controlled, single-center, randomized clinical trial - Protocol and methods (LIVER-PAM).
Rodolpho Augusto de Moura PedroBruna Carla ScharranchLucas de Oliveira AraújoLuciana Severo BrandãoLúcia da Conceição AndradeWellington AndrausLuiz Augusto Carneiro D AlbuquerqueLuiz Marcelo Sá MalbouissonPublished in: Critical care science (2023)
If a 20% reduction in the absolute incidence of renal dysfunction in the postoperative period of liver transplantation is achieved with higher target mean arterial pressure in the first 24 hours, this would represent an inexpensive and simple therapy for improving current outcomes in the management of liver transplant patients.ClinicalTrials.gov Registry: NCT05068713.